In partnership with

Stop Chasing Docs. Automate Them.

Docs piling up faster than you can write them? Same.

Every team knows the feeling — product ships, docs don't. Changelogs get forgotten. Style violations quietly accumulate. Broken links go unnoticed for months.

Mintlify's new Workflows feature fixes this. Define automation rules, and the agent handles the recurring maintenance work for you — on your schedule, by your rules.

Draft docs when a PR merges. Generate changelogs every Friday. Run a style audit on every push. Flag translation lag before it becomes a problem. Each workflow is version controlled, fully configurable, and fits into your existing review process.

You decide when it runs, what it checks, and whether changes get committed directly or opened as a pull request for review.

The result: documentation that actually keeps up with your product, without someone manually chasing it down.

Hi!

Welcome to AIMedily.

We’re on spring break, which means both my kids are home and I’m juggling (or trying to) life at home and work.

I don’t know about you, but I enjoy not having to get them ready for school — and taking a break from my chauffeur job, at least for a week.

Now, let’s dive into today’s issue.

🤖 AIBytes

Researchers evaluated whether AI-supported mammography screening is as safe as standard double reading using the final primary outcome (interval cancer rate) from the MASAI randomized trial.

🔬 Methods

  • Randomized, controlled, non-inferior, single-blinded, population-based screening trial (Sweden)

  • Participants: 105,934 randomized women (≈53k AI vs ≈53k control)

  • Intervention: AI-supported screening

  • Control: Standard double reading without AI

  • AI was used for:

    • triage (single vs double reading)

    • detection support

  • Primary outcome: interval cancer rate (non-inferiority margin 20%)

  • Secondary outcomes: sensitivity, specificity, tumor characteristics

📊 Results

  • Primary outcome: AI-supported screening was non-inferior to standard care for interval cancer

  • Sensitivity: higher with AI

  • Specificity: similar between groups

  • AI detected more small, node-negative cancers

  • AI group had fewer large and aggressive interval cancers

  • AI reduced screen-reading workload (reported in prior MASAI analyses)

🔑 Key Takeaways

  • Large randomized trial (>100,000 women) provides high-level evidence

  • AI-supported screening is as safe as standard double reading

  • AI improves early cancer detection (higher sensitivity)

  • AI may reduce clinically aggressive interval cancers

  • AI acts as triage + support, not replacement

🔗Gommers J, Hernström V, Josefsson V, et al. Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial. Lancet. 2026;407:505–514. doi.org/10.1016/S0140-6736(25)02464-X

Researchers developed CardioNets, a deep learning model that converts a standard 12-lead ECG into cardiac MRI–level information, including functional measurements and synthetic MRI images.

🔬 Methods

  • Multicenter model development and validation study.

  • Data: 159,819 samples from UK Biobank, MIMIC-IV, and external cohorts.

  • Model design:

    • aligns ECG and MRI data in a shared representation.

    • generates MRI-like images from ECG using a generative model.

  • Evaluated for:

    • cardiac measurement prediction

    • disease detection

    • image quality

    • comparison with physicians

📊 Results

  • Better than ECG alone:
    AI improved heart measurements

  • Better disease detection vs ECG:

    • Cardiomyopathy: 0.89 vs 0.87

    • Pulmonary hypertension: 0.88 vs 0.85

  • Better than prior AI for image generation

🔑 Key Takeaways

  • This model does not just read ECGs — it infers MRI-level cardiac structure and function.

  • Outperforms standard ECG models and approaches Cardiac Magnetic Resonance level performance in some tasks.

  • Generated MRI images preserve clinically meaningful information, but do not replace real CMR.

  • Strong potential for low-cost cardiac screening, especially where MRI is not available.

  • Still needs prospective validation before clinical use.

🔗Ding Z, Li Z, Hu Y, et al. Generating cardiac magnetic resonance images from electrocardiograms — a multicenter study. NEJM AI. 2026;3(4). https://doi.org/10.1056/AIoa2500549

🦾TechTools

  • Analyzes brain CT and MRI in real time to support stroke decisions.

  • Identifies core, penumbra, and large vessel occlusion to guide reperfusion therapy.

  • Used clinically to increase thrombectomy rates and reduce treatement time.

  • Portable ultrasound device that connects to a smartphone for point-of-care imaging.

  • Uses a single probe for cardiac, lung, abdominal, vascular, and obstetric scans.

  • New AI feature can estimate gestational age automatically, enabling use even without ultrasound expertise.

  • Built for healthcare environments with HIPAA-aligned workflows.

  • Supports interpretation of clinical data, documents, and research.

  • Key shift: AI models are now being designed specifically for healthcare.

🧬AIMedily Snaps

What’s been happening in AI in medicine this week

  • WHO: Responsible AI for mental health and well-being (Link).

  • AMA: AI use among physicians doubles as confidence grows (Link).

  • Mount Sinai + OpenEvidence integrate AI into the electronic medical record (Link).

  • Google: Moving healthcare AI from research into real-world care (Link).

  • NVIDIA expands AI models targeting healthcare and agentic systems (Link).

  • Microsoft: How Copilot is being used for health-related tasks (Link).

🧪Research Signals

Papers worth your attention this week:

  • Machine learning identifies immune dysregulation in sepsis and pneumonia (Link).

  • Ambient AI scribes and their impact on care, workflow, and the quintuple aim (Link).

  • AI supports extubation decisions using imaging and clinical data in critical care (Link).

  • Human–AI collaboration improves screening of patient-generated health data (Link).

  • Nature: AI–drug combination therapies raise new clinical and regulatory challenges (Link).

  • Nature: Redesigning leadership for clinical AI deployment (Link).

🧩TriviaRX

Which of these was one of the first real clinical uses of AI in medicine?

A) Predicting stroke outcomes
B) Recommending antibiotic therapy
C) Detecting tumors on CT scans
D) Automating medical billing

Let’s take a look at last week’s answer.

B) Pancreatic cancer

AI has detected subtle patterns on CT scans that can signal pancreatic cancer months to years before clinical diagnosis, suggesting potential for earlier detection.

As always, thank you for being a loyal reader!

Feel free to pass this along if it might be useful to someone else ⏩ Forward AIMedily.

Until next week.

Itzel Fer, MD PM&R

Follow me on LinkedIn | Substack | X | Instagram

Forwarded this email? Sign up here

P.S. Help me write a review here (it takes less than a minute ).

How did you like today's newsletter?

Login or Subscribe to participate